Alnylam Pharmaceuticals (ALNY) net assets (shareholders' equity)

Net assets · fiscal 2025
$789.18M

Alnylam Pharmaceuticals (ALNY) had net assets of $789.18M at the end of fiscal 2025 (December 31, 2025). That is 1076.3% higher than the $67.09M of fiscal 2024. Figures as of 19 Nov 2026, 02:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$789.18M
Change on fiscal 2024
+1076.3%
Growth, 5 years
−4.9% a year
Growth, 10 years
−4.6% a year
Highest on record
$1.77Bfiscal 2017
Lowest on record
-$220.64Mfiscal 2023
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Alnylam Pharmaceuticals net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets shrank at a compound 4.9% a year; over ten years the rate was −4.6% a year. Across the 18 fiscal years on record (2008–2025), the highest was $1.77B in fiscal 2017 and the lowest -$220.64M in fiscal 2023.

History · 18 fiscal years

Net assets by fiscal year

Alnylam Pharmaceuticals net assets (shareholders' equity), year by year

Alnylam Pharmaceuticals (ALNY) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$789.18M 1,076.3% up
2024$67.09M—
2023-$220.64M—
2022-$158.22M 126.9% down
2021$588.20M 42.1% down
2020$1.02B 29.4% down
2019$1.44B 10.5% up
2018$1.30B 26.3% down
2017$1.77B 92.0% up
2016$920.22M 27.2% down
2015$1.26B 35.1% up
2014$936.27M 246.3% up
2013$270.35M 101.7% up
2012$134.05M 13.6% up
2011$118.00M 25.4% down
2010$158.23M 11.1% down
2009$177.97M 12.0% down
2008$202.13M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Alnylam Pharmaceuticals and comparable companies
CompanyNet assetsFiscal year
Tenet Healthcare THC$4.22B2025
BioNTech BNTX€19.22B2025
Guardant Health GH-$99.31M2025
Alnylam Pharmaceuticals ALNY$789.18M2025
Zimmer Biomet Holdings ZBH$12.70B2025
Medpace Holdings MEDP$459.07M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ALNY

Alnylam Pharmaceuticals, figure by figure

Alnylam Pharmaceuticals (ALNY) overview: price, valuation and scorecardAll health care companies by market value

Alnylam Pharmaceuticals net assets (shareholders' equity): questions and answers

What are Alnylam Pharmaceuticals's net assets?

Alnylam Pharmaceuticals (ALNY) had net assets of $789.18M at the end of fiscal 2025 (December 31, 2025). That is 1076.3% higher than the $67.09M of fiscal 2024.

What is the growth rate of Alnylam Pharmaceuticals's net assets?

Over the five fiscal years to 2025 net assets shrank at a compound 4.9% a year; over ten years the rate was −4.6% a year.

What are the highest and lowest net assets figures on record for Alnylam Pharmaceuticals?

Across the 18 fiscal years on record (2008–2025), the highest was $1.77B in fiscal 2017 and the lowest -$220.64M in fiscal 2023.

How is Alnylam Pharmaceuticals's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Alnylam Pharmaceuticals it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Alnylam Pharmaceuticals (ALNY) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/ALNY/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.